High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.5M
$3,476,157
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-03-04 | $120,700 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-04 | $702,114x2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-03-03 | $241,400 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-03 | $1,380,149Largex2 | S | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
Other
|
2026-03-02 | $241,400 | M | Form 4 |
| HALO |
HALOZYME THERAPEUTICS, INC.
|
CEO
10b5-1 Sell
|
2026-03-02 | $1,393,894Largex3 | S | Form 4 |